Founder Dr. Rahul Chandola emphasized India's high cardiovascular burden and framed iLive Connect as a broader tool for managing chronic conditions beyond heart disease, including diabetes and COPD.

Continuous monitoring is especially beneficial in the post-discharge window (the first two to four weeks) to detect deterioration early and potentially reduce readmissions.

The post-discharge vulnerability phase is addressed by continuous monitoring, enabling early detection of deterioration and aiming to improve recovery outcomes.

The platform uses multi-day screening to capture real-world physiological data, identifying intermittent or stress-induced abnormalities and building a more comprehensive risk profile than single-point tests.

A doctor-led, AI-enabled platform named iLive Connect was launched in Chennai to provide 24/7 remote medical supervision and continuous vital monitoring outside hospital settings, aiming to reduce sudden cardiac events and improve outcomes for patients with chronic conditions.

A wireless biosensor patch and a wearable wristband continuously monitor vital signs, including heart activity and blood pressure, with 24/7 oversight from doctors at a remote command center who alert patients and families if abnormalities arise.

Dr. Chandola noted that continuous monitoring enables earlier intervention to reduce sudden cardiac events, addressing the limitations of traditional episodic care.

Multi-day monitoring supports early risk stratification and preventive care by providing a full physiological profile beyond one-off measurements.

Real-time data from the patch and wristband is reviewed around the clock by physicians who can trigger timely alerts to patients and families.

Real-time supervision enables timely medical interventions to prevent escalation of illnesses, particularly for chronic patients.

Co-founders Dr. Viveka Kumar and the team describe the platform as an extension of clinical care beyond hospitals, enabling data-driven remote decisions and multi-day heart health screenings over five to seven days for asymptomatic individuals.

Beyond cardiology, the technology is being used to manage chronic conditions such as diabetes, hypertension, COPD, and asthma, and is especially beneficial for independently living elderly patients seeking ongoing medical support.